246 related articles for article (PubMed ID: 23902796)
1. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
[TBL] [Abstract][Full Text] [Related]
2. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
[TBL] [Abstract][Full Text] [Related]
3. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
Piao J; Shang Y; Liu S; Piao Y; Cui X; Li Y; Lin Z
Diagn Pathol; 2014 Mar; 9():67. PubMed ID: 24650035
[TBL] [Abstract][Full Text] [Related]
4. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
5. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
6. DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.
Martinez-Useros J; Rodriguez-Remirez M; Borrero-Palacios A; Moreno I; Cebrian A; Gomez del Pulgar T; del Puerto-Nevado L; Vega-Bravo R; Puime-Otin A; Perez N; Zazo S; Senin C; Fernandez-Aceñero MJ; Soengas MS; Rojo F; Garcia-Foncillas J
BMC Cancer; 2014 Dec; 14():965. PubMed ID: 25515240
[TBL] [Abstract][Full Text] [Related]
7. Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer.
Cai J; Ma H; Huang F; Zhu D; Zhao L; Yang Y; Bi J; Zhang T
Int J Clin Exp Pathol; 2014; 7(8):4959-70. PubMed ID: 25197367
[TBL] [Abstract][Full Text] [Related]
8. DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.
Lee KF; Tsai MM; Tsai CY; Huang CG; Ou YH; Hsieh CC; Hsieh HL; Wang CS; Lin KH
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766266
[TBL] [Abstract][Full Text] [Related]
9. ATAD2 overexpression is associated with progression and prognosis in colorectal cancer.
Hou M; Huang R; Song Y; Feng D; Jiang Y; Liu M
Jpn J Clin Oncol; 2016 Mar; 46(3):222-7. PubMed ID: 26819280
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of DEK is an indicator of poor prognosis in patients with gastric adenocarcinoma.
Ou Y; Xia R; Kong F; Zhang X; Yu S; Jiang L; Zheng L; Lin L
Oncol Lett; 2016 Mar; 11(3):1823-1828. PubMed ID: 26998084
[TBL] [Abstract][Full Text] [Related]
11. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
Zhu J; Chen X; Liao Z; He C; Hu X
Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
[TBL] [Abstract][Full Text] [Related]
12. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
Lee SY; Jung W; Lee J; Kim A; Kim HK; Kim BH
Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
[TBL] [Abstract][Full Text] [Related]
13. Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers.
Cheng X; Tian X; Wu X; Xing X; Du H; Zhou C; Zhang Q; Hao C; Wen X; Ji J
PLoS One; 2016; 11(7):e0158715. PubMed ID: 27391361
[TBL] [Abstract][Full Text] [Related]
14. DEK: A novel early screening and prognostic marker for breast cancer.
Ying G; Wu Y
Mol Med Rep; 2015 Nov; 12(5):7491-5. PubMed ID: 26459608
[TBL] [Abstract][Full Text] [Related]
15. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Martinez-Useros J; Moreno I; Fernandez-Aceñero MJ; Rodriguez-Remirez M; Borrero-Palacios A; Cebrian A; Gomez Del Pulgar T; Del Puerto-Nevado L; Li W; Puime-Otin A; Perez N; Soengas MS; Garcia-Foncillas J
BMC Cancer; 2018 Feb; 18(1):144. PubMed ID: 29409457
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of high NQO1 expression in breast cancers.
Yang Y; Zhang Y; Wu Q; Cui X; Lin Z; Liu S; Chen L
J Exp Clin Cancer Res; 2014 Feb; 33(1):14. PubMed ID: 24499631
[TBL] [Abstract][Full Text] [Related]
18. [Relationship between DEK oncogene expression and oral squamous cell carcinoma].
Wang X; Huang SH; Yu LQ; Liu J; Diao Y; Sun CF
Shanghai Kou Qiang Yi Xue; 2014 Feb; 23(1):75-9. PubMed ID: 24608617
[TBL] [Abstract][Full Text] [Related]
19. Association between ezrin protein expression and the prognosis of colorectal adenocarcinoma.
Lin LJ; Chen LT
Mol Med Rep; 2013 Jul; 8(1):61-6. PubMed ID: 23708420
[TBL] [Abstract][Full Text] [Related]
20. Expression of MSP58 in human colorectal cancer and its correlation with prognosis.
Shi H; Li SJ; Zhang B; Liu HL; Chen CS
Med Oncol; 2012 Dec; 29(5):3136-42. PubMed ID: 22773039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]